Gulf Atlantic

Gulf Atlantic Life Sciences (GALS) is a specialty pharmaceutical company based in Fort Myers, Florida, dedicated to the development and commercialization of high-quality, cost-effective pharmaceutical products. The company focuses on several key therapeutic areas, including respiratory, anti-infective, cardiovascular, and central nervous system (CNS) disorders. Gulf Atlantic Life Sciences maintains a diverse portfolio of generic medications, such as inhalation solutions, and manages a robust pipeline of Abbreviated New Drug Applications (ANDAs). By leveraging strategic partnerships for manufacturing and distribution, the company aims to enhance patient access to essential small molecule therapies. Their business model emphasizes quality and affordability in the specialty pharmaceutical market.